基于多模态超声图像鉴别ACR TI-RADS 3-5类甲状腺结节良恶性的列线图开发与验证
本研究纳入669个ACR TI-RADS 3-5类甲状腺结节,基于灰阶超声、弹性成像和超声造影特征构建预测恶性结节的列线图,训练队列AUC为0.93(95%CI:0.90-0.95),验证队列AUC为0.93(高级和初级放射科医师分别为0.93和0.93),验证队列AUC显著高于单一模态(p<0.005)。
要点
- ACR TI-RADS 4-5类、弹性成像ES-2模式及不均匀低增强、同心低增强、均匀高/等增强是恶性预测因子。
- 联合列线图在训练队列AUC为0.93,敏感度0.84、特异度0.88、阳性预测值0.91、阴性预测值0.81。
- 验证队列列线图AUC显著高于单一模态(p<0.005),高级和初级放射科医师AUC均为0.93。
核心结论
- 联合ACR TI-RADS、弹性成像和超声造影的列线图模型在鉴别ACR TI-RADS 3-5类甲状腺结节良恶性方面显示出潜在的临床应用价值。
研究设计与样本
- 回顾性纳入2014年4月至2018年11月在西京医院行超声造影的2767个甲状腺结节中669个ACR TI-RADS 3-5类且有明确诊断和弹性成像检查的结节,455个为训练队列,214个为验证队列,基于多因素逻辑回归构建列线图并用ROC曲线分析验证。
诊断标准与关键数值
- 训练队列中ACR TI-RADS 4和5类、ES-2模式、不均匀低增强、同心低增强和均匀高/等增强被单因素逻辑回归选为恶性预测因子;列线图训练队列AUC=0.93(95%CI:0.90-0.95),敏感度0.84、特异度0.88、阳性预测值0.91、阴性预测值0.81;验证队列AUC=0.93(95%CI:0.89-0.96),敏感度0.86、特异度0.87、阳性预测值0.87、阴性预测值0.86。
临床应用与阅片要点
- 作者认为联合ACR TI-RADS、弹性成像和超声造影的列线图模型在鉴别ACR TI-RADS 3-5类甲状腺结节良恶性方面具有潜在临床应用价值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The aim of the work described here was to develop and validate a predictive nomogram based on combined image features of gray-scale ultrasonography (US), elastosonography (ES) and contrast-enhanced US (CEUS) to differentiate malignant from benign American College of Radiology Thyroid Imaging, Reporting and Data System (ACR TI-RADS) 3-5 thyroid nodules.
METHODS: Among 2767 thyroid nodules scanned by CEUS in Xijing Hospital between April 2014 and November 2018, 669 nodules classified as ACR TI-RADS 3-5 were included, with confirmed diagnosis and ES examination. Four hundred fifty-five nodules were set as a training cohort and 214 as a validation cohort. Images were categorized as gray-scale US ACR TI-RADS 3, TI-RADS 4 and TI-RADS 5; ES patterns of ES-1 and ES-2; and CEUS patterns of either heterogeneous hypo-enhancement, concentric hypo-enhancement, homogeneous hyper-/iso-enhancement, no perfusion, hypo-enhancement with sharp margin, island-like enhancement or ring-like enhancement. On the basis of multivariate logistic regression analysis, a predictive nomogram model was developed and validated by receiver operating characteristic curve analysis.
RESULTS: In the training cohort, ACR TI-RADS 4 and 5, ES-2, heterogeneous hypo-enhancement, concentric hypo-enhancement and homogeneous hyper-/iso-enhancement were selected as predictors of malignancy by univariate logistic regression analysis. A predictive nomogram (combining indices of ACR TI-RADS, ES and CEUS) indicated excellent predictive ability for differentiating malignant from benign lesions in the training cohort: area under the receiver operating characteristic curve (AUC) = 0.93, 95% confidence interval (CI): 0.90-0.95. The prediction nomogram model was determined to have a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 0.84, 0.88, 0.91 and 0.81. In the validation cohort, the AUC of the prediction nomogram model was significantly higher than those of the single modalities (p < 0.005) . The AUCs of the validation cohort were 0.93 (95% CI: 0.89-0.96) and 0.93 (95% CI: 0.89-0.97), respectively, for senior and junior radiologists. The prediction nomogram model has a sensitivity, specificity, PPV and NPV of 0.86, 0.87, 0.87 and 0.86.
CONCLUSION: A predictive nomogram model combining ACR TI-RADS, ES and CEUS exhibited potential clinical utility in differentiating malignant from benign ACR TI-RADS 3-5 thyroid nodules.
引用
- Pang L, Yang X, Zhang P, et al. Development and Validation of a Nomogram Based on Multimodality Ultrasonography Images for Differentiating Malignant from Benign American College of Radiology Thyroid Imaging, Reporting and Data System (TI-RADS) 3-5 Thyroid Nodules. Ultrasound Med Biol. 2024. PMID: 38262884. doi:10.1016/j.ultrasmedbio.2023.12.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。